Brief

The TGA issued 4 infringement notices totalling $75,120 to Summit Pharmacy Pty Ltd for alleged unlawful manufacturing of medicinal cannabis products. The pharmacy was found to be manufacturing medicinal cannabis oils in bulk amounts, contravening the Therapeutic Goods Act 1989. Compliance with regulatory requirements is essential prior to manufacturing and supplying compounded medicinal cannabis products; failure to comply may result in enforcement action, including infringement notices or civil proceedings.

This content is restricted.

Highlights content goes here...

This content is restricted.

Therapeutic Goods Administration (TGA)

Quick Insight
RADA.AI
RADA.AI
Hello! I'm RADA.AI - Regulatory Analysis and Decision Assistance. Your Intelligent guide for compliance and decision-making. How can i assist you today?
Suggested

Form successfully submitted. One of our GRI rep will contact you shortly

Thanking You!

Enter your Email

Enter your registered username/email id.

Enter your Email

Enter your email id below to signup.
Individual Plan
$125 / month OR $1250 / year
Features
Best for: Researchers, Legal professionals, Academics
Enterprise Plan
Contact for Pricing
Features
Best for: Law Firms, Corporations, Government Bodies